These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 36368285)

  • 1. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
    Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
    Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xihuang pills targeting the Warburg effect through inhibition of the Wnt/β-catenin pathway in prostate cancer.
    Lin F; Long Y; Li M; Cai C; Wu Y; You X; Tian X; Zhou Q
    Heliyon; 2024 Jun; 10(12):e32914. PubMed ID: 38994113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma.
    Tu H; Li J; Xu W; Wang Z; Wang L
    Altern Ther Health Med; 2023 Oct; 29(7):148-154. PubMed ID: 37442189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
    Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
    Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway.
    Teng YJ; Deng Z; Ouyang ZG; Zhou Q; Mei S; Fan XX; Wu YR; Long HP; Fang LY; Yin DL; Zhang BY; Guo YM; Zhu WH; Huang Z; Zheng P; Ning DM; Tian XF
    World J Gastrointest Oncol; 2022 Apr; 14(4):872-886. PubMed ID: 35582102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the mechanism of action of YQYYJD prescription in the treatment of non-small cell lung cancer using transcriptomics analysis.
    Yin Y; Wang Y; Wang C; Zhang Y; Qi A; Song J; Xu L; Yang W; Jiao L
    J Ethnopharmacol; 2024 May; 326():117984. PubMed ID: 38428661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Regulation Mechanism of Xihuang Pill,
    Yang K; Zeng L; Ge A; Bao T; Xu T; Xie X; Liu L
    Front Pharmacol; 2020; 11():825. PubMed ID: 32595497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xihuang pill ameliorates colitis in mice by improving mucosal barrier injury and inhibiting inflammatory cell filtration through network regulation.
    Hu ML; Liao QZ; Liu BT; Sun K; Pan CS; Wang XY; Yan L; Huo XM; Zheng XQ; Wang Y; Zhong LJ; Liu J; He L; Han JY
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117098. PubMed ID: 37640256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Pharmacological Mechanisms of Xihuang Pills Against Prostate Cancer
    Wu Y; You X; Lin Q; Xiong W; Guo Y; Huang Z; Dai X; Chen Z; Mei S; Long Y; Tian X; Zhou Q
    Front Pharmacol; 2021; 12():791269. PubMed ID: 35342388
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway.
    Zhuo Y; Li S; Hu W; Zhang Y; Shi Y; Zhang F; Zhang J; Wang J; Liao M; Chen J; Qian H; Li D; Sun C
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35577506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer.
    Wu J; Luo D; Li S
    Breast Cancer (Dove Med Press); 2020; 12():267-277. PubMed ID: 33324095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xihuang pill promotes apoptosis of Treg cells in the tumor microenvironment in 4T1 mouse breast cancer by upregulating MEKK1/SEK1/JNK1/AP-1 pathway.
    Su L; Jiang Y; Xu Y; Li X; Gao W; Xu C; Zeng C; Song J; Weng W; Liang W
    Biomed Pharmacother; 2018 Jun; 102():1111-1119. PubMed ID: 29710529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of Xuanhuang Pill in protecting against alcohol liver disease using ultra-performance liquid chromatography/time-of-flight mass spectrometry and network pharmacology.
    Cui X; Du M; Wei K; Dai C; Yang RYH; Zhou B; Luo Z; Yang X; Yu Y; Lin W; Wu Y; Liu Y
    Front Endocrinol (Lausanne); 2023; 14():1175985. PubMed ID: 37082132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yi Qi Chu Tan Formula (YQCTF) inhibited the progress of lung cancer via regulating tumor-associated neutrophil: An integrated study of network pharmacology, proteomics and pharmacodynamics.
    Le-Xin C; Ming-Jun L; Chun-Qi X; Jia-Xin Z; Jing-Ya Y; Li-Xin N; Mei-Qi W; En-Xin Z; Xiao-Jun Z
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116943. PubMed ID: 37532072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
    Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
    Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xihuang pill induces pyroptosis and inhibits progression of breast cancer cells via activating the cAMP/PKA signalling pathway.
    Chen C; Yuan S; Chen X; Xie J; Wei Z
    Am J Cancer Res; 2023; 13(4):1347-1362. PubMed ID: 37168335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune cell infiltration.
    Zhao Q; Sun Z; Pan Y; Jing Q; Li W; Wang C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):311-322. PubMed ID: 37164914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-solanine Anti-tumor Effects in Non-small Cell Lung Cancer Through Regulating the Energy Metabolism Pathway.
    Zou T; Gu L; Yang L; Wei J; Zhao Y; Shen J; Li M; Wu X; Du F; Chen Y; Ye Y; Xiao Z; Wu Z
    Recent Pat Anticancer Drug Discov; 2022; 17(4):396-409. PubMed ID: 35049438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.